Rico Laage has more than 20 years experience in clinical development and Life Science R&D. He joined Heidelberg ImmunoTherapeutics in 2018 where he is responsible for coordinating and accompanying the development of the clinical pipeline as senior consultant. In 2014 he founded ‘Guided Development’, where he has an established track record in successfully supporting various start-up and clinical stage biopharma companies as strategic advisor and experienced project lead. 
Since 2001 he held various positions in translational research and clinical development in the Biotech industry. In this role he was planning and leading several clinical trials from first-in-human to multinational phase III studies. Rico Laage obtained his PhD in cell biology at Heidelberg University, he is author of more than 40 scientific publications and patents in the area of life science and clinical development.